Diabetes mellitus and ovarian cancer risk : A systematic review and meta-analysis of observational studies

International Journal of Gynecological Cancer

Volumn 23, Issue 3, 2013, Pages 402-412

  Lee, Jung Yun ^a   Jeon, InPyo ^b   Kim, Jae Weon ^a   Song, Yong Sang ^a   Yoon, Jae Moon ^a   Park, Sang Min ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Korea Health Promotion Foundation   (South Korea)

Author keywords

Diabetes mellitus; Incidence; Meta analysis; Ovarian cancer; Risk

Indexed keywords

ALCOHOL CONSUMPTION; BODY MASS; CANCER RISK; CASE CONTROL STUDY; COCHRANE LIBRARY; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; EMBASE; GROUPS BY AGE; HUMAN; MEDLINE; OBSERVATIONAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PUBLISHING; REVIEW; RISK ASSESSMENT; SMOKING; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; META-ANALYSIS AS TOPIC; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 84876229777     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31828189b2     Document Type: Review

References (51)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95:S161-S192.
3. Hennessy BT, Coleman RL, Markman M. Ovarian cancer. Lancet. 2009;374:1371-1382.
4. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31-40.
5. Choi YJ, Kim HC, Kim HM, et al. Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998-2005. Diabetes Care. 2009;32:2016-2020.
6. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J. 2011;35:303-308.
7. Ben Q, Xu M, Ning X, et al. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer. 2011;47:1928-1937.
8. Yang WS, Va P, Bray F, et al. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: A meta-analysis of prospective cohort studies. PLoS One. 2011;6:e27326.
9. Deng L, Gui Z, Zhao L, et al. Diabetes mellitus and the incidence of colorectal cancer: An updated systematic reviewand meta-analysis. Dig Dis Sci. 2012;57:1576-1585.
10. Friberg E, Orsini N, Mantzoros CS, et al. Diabetes mellitus and risk of endometrial cancer: A meta-analysis. Diabetologia. 2007;50:1365-1374.
11. Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:2056-2062.
12. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
13. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1-30.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
15. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820-826.
16. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
17. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
18. Peters JL, Sutton AJ, Jones DR, et al. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61:991-996.
19. O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: A multisite case-control study. J Chronic Dis. 1985;38:435-441.
20. Adler AI, Weiss NS, Kamb ML, et al. Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States). Cancer Causes Control. 1996;7:475-478.
21. Parazzini F, Moroni S, La Vecchia C, et al. Ovarian cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer. 1997;33:1634-1637.
22. Kuriki K, Hirose K, Tajima K. Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev. 2007;16:83-89.
23. Reis N, Kizilkaya Beji N. Risk factors for ovarian cancer: Results from a hospital-based case-control study. Turkiye Klin J Med Sci. 2010;30:79-87.
24. Bosetti C, Rosato V, Polesel J, et al. Diabetes mellitus and cancer risk in a network of case-control studies. Nutr Cancer. 2012;64:643-651.
25. Attner B, Landin-Olsson M, Lithman T, et al. Cancer among patients with diabetes, obesity and abnormal blood lipids: A population-based register study in Sweden. Cancer Causes Control. 2012;23:769-777.
26. Inoue M, Iwasaki M, Otani T, et al. Diabetes mellitus and the risk of cancer: Results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166:1871-1877.
27. Khan M, Mori M, Fujino Y, et al. Site-specific cancer risk due to diabetes mellitus history: Evidence from the Japan Collaborative Cohort (JACC) study. Asian Pac J Cancer Prev. 2006;7:253-259.
28. Rapp K, Schroeder J, Klenk J, et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia. 2006;49:945-952.
29. Stattin P, Bjor O, Ferrari P, et al. Prospective study of hyperglycemia and cancer risk. Diabetes Care. 2007;30:561-567.
30. Chodick G, Heymann AD, Rosenmann L, et al. Diabetes and risk of incident cancer: A large population-based cohort study in Israel. Cancer Causes Control. 2010;21:879-887.
31. Bjorge T, Lukanova A, Tretli S, et al. Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project. Int J Epidemiol. 2011;40:1667.
32. Johnson JA, Bowker SL, Richardson K, et al. Time-varying incidence of cancer after the onset of type 2 diabetes: Evidence of potential surveillance bias. Diabetes. 2011;60:A69.
33. Lambe M, Wigertz A, Garmo H, et al. Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer. Cancer Causes Control. 2011;22:1163-1171.
34. Wotton CJ, Yeates DG, Goldacre MJ. Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: Record linkage studies. Diabetologia. 2011;54:527-534.
35. Lo SF, Chang SN, Muo CH, et al. Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients. Int J Cancer. 2012;21:2000-2005.
36. Gapstur SM, Patel AV, Diver WR, et al. Type 2 diabetes mellitus and the incidence of epithelial ovarian cancer in the Cancer Prevention Study-II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2012;132:182-188.
37. Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293:194-202.
38. Khaw KT, Wareham N, Bingham S, et al. Preliminary communication: Glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: A prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev. 2004;13:915-919.
39. Mulholland HG, Murray LJ, Cardwell CR, et al. Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: A systematic review and meta-analysis. Br J Cancer. 2008;99:434-441.
40. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: A consensus report. Diabetes Care. 2010;33:1674-1685.
41. Kellenberger LD, Bruin JE, Greenaway J, et al. The role of dysregulated glucose metabolism in epithelial ovarian cancer. J Oncol. 2010;2010:514310.
42. Resnicoff M, Ambrose D, Coppola D, et al. Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab Invest. 1993;69:756-760.
43. Kalli KR, Falowo OI, Bale LK, et al. Functional insulin receptors on human epithelial ovarian carcinoma cells: Implications for IGF-II mitogenic signaling. Endocrinology. 2002;143:3259-3267.
44. Gann PH, Hennekens CH, Ma J, et al. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst. 1996;88:1118-1126.
45. Haffner SM, Shaten J, Stern MP, et al. Low levels of sex hormone-binding globulin and testosterone predict the development of nonYinsulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996;143:889-897.
46. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998;90:1774-1786.
47. Legro RS. Insulin resistance in polycystic ovary syndrome: Treating a phenotype without a genotype. Mol Cell Endocrinol. 1998;145:103-110.
48. Olsen CM, Green AC, Whiteman DC, et al. Obesity and the risk of epithelial ovarian cancer: A systematic review and meta-analysis. Eur J Cancer. 2007;43:690-709.
49. Leitzmann MF, Koebnick C, Danforth KN, et al. Body mass index and risk of ovarian cancer. Cancer. 2009;115:812-822.
50. Poschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol. 2004;39:155-165.
51. Ovarian cancer and smoking: Individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol. 2012;13:946-956.